| Financial Year |
March 31 2023 |
| Monetary Funds |
406,002,232.66 |
| Held-for-trading Financial Assets |
47,410,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
39,265,336.04 |
| Advances to Suppliers |
28,152,005.21 |
| Other Receivables |
51,216,584.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,770,286.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,513,552.50 |
| Total Current Assets |
739,329,997.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,435,008.26 |
| Fixed Assetes |
1,004,665,297.06 |
| Under-construction Projects |
243,955,100.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,875,890.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
296,825,893.29 |
| Deferred Income Tax Assets |
18,756,373.61 |
| Other Non-Current Assets |
181,986,583.25 |
| Sub-Total of Non-Current Assets |
2,438,686,204.83 |
| Total Assets |
3,178,016,202.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
239,993,885.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,947,662.04 |
| Taxes Payable |
22,583,025.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
158,446,371.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,152,623.95 |
| Other Current Liabilities |
4,359,129.32 |
| Sub-Total of Current Liabilities |
602,978,541.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
224,321.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
516,671,106.20 |
| Total Liabilities |
1,119,649,647.75 |
| Paid-In Capital(Or Share Stock) |
260,000,000.00 |
| Capital Surplus |
741,984,728.73 |
| Surplus Reserve |
89,054,195.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
967,327,629.80 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,058,366,554.28 |
| Owner's Equity（Stockholder's Equity） |
2,058,366,554.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,178,016,202.03 |
